Durvalumab vs Ondansetron

## Durvalumab vs Ondansetron: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Ondansetron**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Ondansetron**: Selective 5-HT3 receptor antagonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Ondansetron — 3-5 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Ondansetron — C18H19N3O.

**Molecular Weight**: Durvalumab — N/A; Ondansetron — 293.3660 g/mol.

**Type**: Durvalumab — Antibody; Ondansetron — Small molecule.